IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#3742
Positioning
Market Dominance
Manufacturing
Pharmaceutical Products
$82M
Josh Mandel-Brehm
We are a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases. Our principal executive offices are located in Cambridge, Massachusetts.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 32.9% | 20.5% | 48.8% | 30.6% | 24.4% | 7.7% | 0.9% | 32.0x | $148.6B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.4% | 7.5% | 68.3% | 19.5% | 18.2% | 29.0% | 0.0% | 0.0x | $84M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$CAMP CalAmp Corp. | 38 | 36 | 29 | 62 | - | - | -213.3% | -144.8% | 32.8% | -1067.4% | -1086.9% | -98.7% | 0.0% | 47.0x | $82M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -1.9% | 0.9% | 44.1% | 2.5% | 1.0% | 6.7% | 0.0% | 0.2x | - | REF |
CalAmp Corp. (CAMP) receives a "Avoid" rating with a composite score of 38.4/100. It ranks #3742 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Outperforming peers — winners tend to keep winning over 3-12 months
Expensive relative to fundamentals — limited margin of safety
Average quality profile
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for CAMP.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 36 | 24 | +12ALPHA |
| MOMENTUM | 62 | 64 | -2NEUTRAL |
| VALUATION | 29 | 18 | +11ALPHA |
| INVESTMENT | 25 | 13 | +12ALPHA |
| STABILITY | 32 | 19 | +13ALPHA |
| SHORT INT | 27 | 16 | +11ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -213.3% (sector -1.9%)
GM 33% vs sector 44%, OM -1067% vs sector 3%
Capital turnover N/A, R&D intensity 947.5%
Rev growth -99%, 10yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate CalAmp Corp. (CAMP) as Avoid with a composite score of 38.4/100 at a current price of $4.74. The stock falls in the bottom quintile, and the multi-factor weakness suggests a high probability of continued underperformance.
CalAmp Corp. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 38.4/100 places it at rank #3742 in our full universe.
The near-term outlook is constructive, with revenue growing at -99% and momentum in the 62th percentile confirming positive market sentiment. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy.
No Moat
Medium
Poor
Fair Value
Stable competitive position in a defensive sector.
Vulnerability to macroeconomic shocks and interest rate volatility.
CalAmp Corp. represents a avoid based on multi-factor quantitative performance.
Our quantitative model flags CalAmp Corp. with an Avoid rating, assigning a composite score of 38.4/100 and 1 out of 5 stars. Ranked #3742 of 7,333 stocks, CAMP falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
CAMP's quality score of 36/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -213.3% (sector avg: -1.9%), gross margins of 32.8% (sector avg: 44.1%), net margins of -1086.9% (sector avg: 1.0%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
CAMP registers a value score of just 29/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 3.84x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
CalAmp Corp.'s investment score of 25/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -98.7% vs. a sector average of 6.7% and a return on assets of -144.8% (sector: 0.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
CAMP demonstrates moderate momentum with a score of 62/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at -98.7% year-over-year, while a beta of 0.77 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
CAMP's stability score of 32/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 0.77 and a debt-to-equity ratio of 47.00x (sector avg: 0.2x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
CalAmp Corp.'s short interest score of 27/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 47.00x), micro-cap liquidity risk. At $82M (micro-cap), CAMP carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
CalAmp Corp. is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #3742 of 7,333 overall (49th percentile). Key comparisons include ROE of -213.3% trailing the -1.9% sector median and operating margins of -1067.4% below the 2.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While CAMP currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Investment (25) would have the largest impact on the composite score.
ROE 11125% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 26% BELOW SECTOR MEDIAN
Op. Margin 42627% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
American Superconductor (AMSC) delivered earnings and revenue surprises of 266.67% and 14.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Ballard (BLDP) delivered earnings and revenue surprises of -7.69% and 12.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
If you are closing in on $1 million in retirement savings, it can feel like you finally made it. Years of discipline, investing and saying no to lifestyle creep appear to have paid off. But certified financial planner Rachael Camp says that milestone can create problems the moment you say it out loud. “The first big shift happens the second someone hears your number,” Camp said in a recent video. What you see as an honest update can quickly be interpreted as, “You’re rich. You’re set.” And that
The parents of an 8-year-old Texas girl who vanished last summer when the Hill Country was inundated by flash flooding are suing the operators of Camp Mystic.
Chloe Lee, a financial advisor, describes how solo surf camp trips in Bali boosted her confidence and built global friendships.